Book description
Managing patients with thrombotic vascular disease is complex and challenging:
- Ischemic vascular disease remains a complicated interplay of
atherosclerosis and thrombosis-even with the evolution in our
understanding of the pathobiology of thrombosis.
- There has been tremendous growth in therapeutic options which are
quickly finding their place in daily practice, including a
remarkable expansion in the number of intravenous and oral
antithrombotic agents and new antiplatelet agents
Now more than ever, all cardiologists, hematologists, and specialists
in vascular medicine, as well as other professionals, such as hospital
pharmacists, who deal with prognosis and intervention in preventing
thrombosis, need a resource that distills current knowledge of this
important subject.
Written and edited by today's leading international,
Therapeutic Advances in Thrombosis, 2e provides
physicians with the very latest in medical and surgical advances in
antithrombotic therapies. With this comprehensively updated edition
you get:
- Coverage of virtually all aspects of venous and arterial
thrombotic disease and the corresponding therapies
- Strategies to manage specific clinical conditions and how to
tailor treatment to individual patient needs
- Updated chapters covering thrombolysis in ST-elevated myocardial
infarctions; thrombosis in patients with diabetes, pregnancy, and
renal dysfunction
- Special emphasis on the pharmacology of novel anticoagulants and
their practical use in venous thromboembolism and atrial fibrillation.
Plus, all chapters fully explore clinical trial designs and outcomes
for particular treatment therapies, as well as contain the relevant
ACC/AHA/ESC guidelines, so you can confidently apply what you learn.
